On January 4, 2021, one of the most closely watched experiments in American healthcare came to an end. Haven Healthcare, created by Amazon, Berkshire Hathaway, and JPMorgan Chase, was shutting down less than three years after its launch.
Its CEO had already stepped down. Its COO had left before him. The remaining employees would be absorbed back into the companies that created it.
So what happened?
In Part 1 of this four-part Viral Healthcare series, Bruce Spurlock deliberately avoids starting with that question. Once we know how a story ends, hindsight makes it easy to identify all the reasons failure seems inevitable. Instead, Bruce takes us back to January 2018 and asks what Haven looked like to the people making decisions at the time.
Three enormously successful companies. More than a million employees. Extraordinary access to capital, technology, data, purchasing power, and talent. A healthcare system almost everyone agreed needed improvement. Then, six months later, the venture selected physician, researcher, author, and healthcare thinker Dr. Atul Gawande as its leader.
On paper, it was difficult not to believe Haven had a real chance.
But underneath the excitement was a much harder question: What exactly were they trying to fix?
Bruce explores the difference between a compelling purpose and an implementable aim, the complexity of trying to disrupt an interconnected healthcare system, the challenge of governing an independent organization with three powerful owners, and the decisions Haven's leaders faced before anyone knew how the story would end.
And he leaves us with the decision Haven itself had to make: Do you use extraordinary resources to rethink healthcare broadly, or narrow the problem to one population, one market, and one measurable outcome, prove it works, and then spread?
In Part 2: Who loses if Haven Healthcare wins?
Hosted on Acast. See acast.com/privacy for more information.